Lipocalin 2, an iron-binding protein, and its receptor were exclusively expressed in cancer cells in the CSF of five patients with breast and lung cancer LC, which was confirmed by ELISA and flow cytometry. The authors, moreover, showed inhibition of cancer growth when iron chelation therapy was applied [90]. Here, LCN2 is linked to cancer.